Production & Manufacturing
Manufacturing

Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products Case Studies

Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products

Increase specific Influenza production The vaccine industry is challenged to produce large quantities of vaccines in a rapid and cost-effective way. Major changes to current bioprocesses are both difficult and very expensive to implement.
Read case study
Optimization of CHO-S Cell culture medium by supplementation with non-animal-derivedcomponents using design of experiments (DOE) Puente, E., Quintanilla, D., Gutiérrez-Granados, S.,Gòdia, F., Cervera, L. Cell and Bioprocess Engineering Research Group Departament d’EnginyeriaQuímica, Universitat Autònoma de Barcelona. Edifici Q, 08193, Bellaterra, Barcelona, Spain
Read case study
Insulin increases influenza virus yield in HEK293 cells for vaccine production Human Health Therapeutics, Vaccine Program
Read case study
Defining Non-Animal Derived Supplements For the Optimisation of Mammalian Cell Culture Media Using DoE Methodologies Francesc Gòdia, Department of Chemical Engineering, Universitat Autònoma de Barcelona.
Read case study